Key facts
- It has raised $930K; the latest was Seed Round in Dec 2024.
- Notable investors include US National Science Foundation, SOSV, National Institutes of Health, IndieBio, Astanor — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Unlocked Labs (Laramie)
- ·The full record, as it builds
Funding rounds
No funding rounds for Unlocked Labs (Laramie) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Unlocked Labs (Laramie)
Developer of medical foods designed to manage chronic health conditions by targeting harmful dietary compounds in the digestive tract. The company offers shelf-stable active postbiotic ingredients that break down specific dietary and metabolic compounds during digestion, enabling physicians and patients managing diet-related chronic conditions to reduce health risks through controlled nutritional intake.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Laramie, WY, United States
- Founded
- 2020
- Employees
- 4
- Website
- unlocked.bio/
- Ownership
- Privately Held (backing)
Unlocked Labs (Laramie) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Unlocked Labs (Laramie) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Unlocked Labs (Laramie) in its N-PORT filings yet. We sweep new filings monthly.